4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-082485
Chief Scientific Officer sold 8,000 shares at $16.33 ($130,640)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-082485
Chief Scientific Officer sold 8,000 shares at $16.33 ($130,640)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…